2 weeks Ago By ABMN Staff
InfuSystem Holdings, Inc. ( NYSE:INFU – Free Report ) – Stock analysts at B. Riley issued their Q3 2024 earnings estimates for shares of InfuSystem in a research note issued to investors on Wednesday, September 25th.
B. Riley analyst K. Bauser anticipates that the company will post earnings of $0.
08 per share for the quarter. B. Riley has a “Strong-Buy” rating on the stock.
B. Riley also issued estimates for InfuSystem’s Q4 2024 earnings at $0.10 EPS, FY2024 earnings at $0.
17 EPS, Q1 2025 earnings at $0.09 EPS, Q2 2025 earnings at $0.09 EPS, Q3 2025 earnings at $0.
09 EPS, Q4 2025 earnings at $0.10 EPS, FY2025 earnings at $0.37 EPS and FY2026 earnings at $0.
49 EPS. Separately, StockNews.com cut shares of InfuSystem from a “strong-buy” rating to a “buy” rating in a research note on Saturday.
InfuSystem Stock Up 2.9 % NYSE:INFU opened at $6.75 on Monday.
The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.64 and a current ratio of 2.
07. InfuSystem has a fifty-two week low of $5.74 and a fifty-two week high of $10.
99. The firm has a market cap of $143.74 million, a PE ratio of -675,000.
00 and a beta of 1.46. InfuSystem ( NYSE:INFU – Get Free Report ) last announced its quarterly earnings data on Thursday, August 8th.
The company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.04 by ($0.
01). InfuSystem had a net margin of 0.28% and a return on equity of 0.
70%. The firm had revenue of $33.70 million during the quarter.
Institutional Investors Weigh In On InfuSystem Large investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. lifted its holdings in InfuSystem by 1.
7% in the 1st quarter. Vanguard Group Inc. now owns 1,083,730 shares of the company’s stock valued at $9,288,000 after purchasing an additional 18,432 shares in the last quarter.
Wasatch Advisors LP lifted its holdings in InfuSystem by 3.4% in the 4th quarter. Wasatch Advisors LP now owns 846,609 shares of the company’s stock valued at $8,923,000 after purchasing an additional 27,881 shares in the last quarter.
Ranger Investment Management L.P. lifted its holdings in shares of InfuSystem by 4.
7% during the 4th quarter. Ranger Investment Management L.P.
now owns 689,842 shares of the company’s stock worth $7,271,000 after acquiring an additional 30,835 shares during the period. First Eagle Investment Management LLC lifted its holdings in shares of InfuSystem by 10.0% during the 2nd quarter.
First Eagle Investment Management LLC now owns 666,048 shares of the company’s stock worth $4,549,000 after acquiring an additional 60,813 shares during the period. Finally, Bank of New York Mellon Corp lifted its holdings in shares of InfuSystem by 6.1% during the 2nd quarter.
Bank of New York Mellon Corp now owns 93,899 shares of the company’s stock worth $641,000 after acquiring an additional 5,391 shares during the period. 71.13% of the stock is owned by institutional investors and hedge funds.
InfuSystem Company Profile ( Get Free Report ) InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.
Featured Articles Receive News & Ratings for InfuSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InfuSystem and related companies with MarketBeat.com's FREE daily email newsletter ..
